We’re the leading resource for those affected by bleeding disorders. You can count on our organization to ensure your voice is heard. It’s with your help that we can make a difference. Learn more and get involved.

Spark Reports Positive Data from Hemophilia B Gene Therapy Program

Gene therapy clinical trials eliminate infusions in some patients and improve quality of life.

Planning to Renew or Enroll in the Healthcare Marketplace for 2017?

December 15th is the deadline to enroll in or change plans for coverage starting January 1, 2017. Take time to review your coverage today.

Sangamo Reports Hemophilia A Gene Therapy Progress at ASH

Trials of Sangamo's gene therapy called SB-525 show promising results in animals with hemophilia A.

Subscribe to Our Newsletter

Fill in the fields below to receive our email newsletter.